Fibromyalgia (FM) is a chronic pain condition affecting 2 to 4% of the population. It is characterized by widespread pain and often accompanied by other symptoms like sleep problems, depression, cognitive dysfunction, and fatigue. Many individuals with FM experiment with alternative interventions to manage their symptoms, including cannabidiol (CBD). This study, conducted by KF Boehnke and colleagues, is a cross-sectional, anonymous survey examining the patterns of CBD use among individuals with FM.
About the Authors and InstitutionThe study was conducted by a team of researchers led by KF Boehnke. The team has expertise in cannabinoids and chronic pain, and they designed the survey based on commonly asked questions about CBD in the FM community. The study was published in The Journal of Pain, a reputable scientific journal.
- 38.1% of participants reported never using CBD, 29.4% reported past CBD use, and 32.4% reported current CBD use.
- Those using CBD typically did so due to inadequate symptom relief, while those not using CBD typically cited safety concerns.
- Two-thirds of participants disclosed CBD use to their physician, although only 33% asked for physician advice on using CBD.
- Participants used CBD for numerous FM-related symptoms (most commonly pain), and generally reported slight to much improvement across symptom domains.
- Around half of participants reported side effects, which were typically minor.